Publications by authors named "Wyndham Wilson"

100Publications

Reply to M. Hertzberg et al.

J Clin Oncol 2020 Sep 15:JCO2002290. Epub 2020 Sep 15.

Mark Roschewski, MD, Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD; Kieron Dunleavy, MD, George Washington University Cancer Center, Washington, DC; and Wyndham H. Wilson, MD, PhD, Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.02290DOI Listing
September 2020

Expanding the Precision Medicine Toolkit With Circulating Tumor DNA.

JCO Oncol Pract 2020 Sep;16(9):569-570

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/OP.20.00629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489484PMC
September 2020

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.

Sci Immunol 2020 06 5;5(48). Epub 2020 Jun 5.

Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, MD; Willamette Valley Cancer Institute and Research Center, US Oncology, Eugene, OR; Hematology-Oncology Department, Walter Reed National Military Medical Center, Bethesda, MD; John Theurer Cancer Center, Hackensack Meridian and School of Medicine at Seton Hall, NJ; Rocky Mountain Cancer Center, US Oncology, Colorado Springs, CO; Department of Emergency Medicine, Penrose-St. Francis Health Services, Colorado Springs, CO; US Acute Care Solutions, Canton, OH; Department of Medicine, St. Peter's Hospital and US Oncology, Albany, NY; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD; Acerta Pharma, South San Francisco, CA; Biometric Research Branch, Division of Cancer Diagnosis and Treatment, National Cancer Institute, Bethesda, MD, USA AstraZeneca, One MedImmune Way, Gaithersburg, MD

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/sciimmunol.abd0110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274761PMC
June 2020

Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma.

Cancer J 2020 May/Jun;26(3):195-205

From the Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285963PMC
May 2021

Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder.

Blood 2020 04;135(16):1344-1352

Lymphoid Malignancies Branch, Center for Cancer Research and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019000933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162687PMC
April 2020

The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.

Hematol Oncol 2020 Feb 30;38(1):34-37. Epub 2019 Dec 30.

National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2704DOI Listing
February 2020

Reply to T.M. Weis et al.

J Clin Oncol 2019 11 18;37(31):2953. Epub 2019 Sep 18.

Nancy L. Bartlett, MD, Washington University School of Medicine, St Louis, MO; Wyndham H. Wilson, MD, PhD, National Institutes of Health, Bethesda, MD; and John P. Leonard, MD, Weill Medical College of Cornell University, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01617DOI Listing
November 2019

Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase.

Front Immunol 2019 27;10:2000. Epub 2019 Aug 27.

Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.02000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718476PMC
October 2020

Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.

Immunol Rev 2019 09;291(1):190-213

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imr.12792DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693651PMC
September 2019

Reply to M. Skelin et al.

J Clin Oncol 2019 10 7;37(28):2584-2585. Epub 2019 Aug 7.

Wyndham H. Wilson, MD, PhD and Louis Staudt, MD, PhD, National Cancer Institute, Bethesda, MD; and Anas Younes, MD, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01603DOI Listing
October 2019

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.

Cell 2019 07 4;178(3):699-713.e19. Epub 2019 Jul 4.

Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2019.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380118PMC
July 2019

Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma.

Leuk Lymphoma 2019 12 17;60(13):3320-3323. Epub 2019 Jun 17.

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1627540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917991PMC
December 2019

Liquid biopsy in non-Hodgkin's lymphoma.

Hematol Oncol 2019 Jun;37 Suppl 1:70-74

Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892-1203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2587DOI Listing
June 2019

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care - Authors' reply.

Authors:
Wyndham H Wilson

Lancet Haematol 2019 03;6(3):e120

Lymphoma Therapeutics Section, National Cancer Institute, Bethesda, MD 20810, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30020-1DOI Listing
March 2019

Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma.

Hepatol Commun 2019 Feb 28;3(2):220-226. Epub 2018 Dec 28.

Liver and Energy Metabolism Unit, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep4.1304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357828PMC
February 2019

Reply to J. Wang et al.

J Clin Oncol 2019 03 12;37(9):755-757. Epub 2019 Feb 12.

David M. Kurtz, MD, PhD; Florian Scherer, MD; Michael C. Jin; Joanne Soo; Alexander F.M. Craig, MPhil; Mohammad S. Esfahani, PhD; Jacob J. Chabon, PhD; Henning Stehr, PhD; Chih Long Liu, PhD; Robert Tibshirani, PhD; Lauren S. Maeda, MD; Neel K. Gupta, MD; Michael S. Khodadoust, MD, PhD; Ranjana H. Advani, MD; and Aaron M. Newman, PhD, Stanford University, Stanford, CA; Ulrich Dührsen, MD; and Andreas Hüttmann, MD, University Hospital Essen, Essen, Germany; Michel Meignan, MD, PhD, Hôpitaux Universitaires Henri Mondor, Creteil, France; Olivier Casasnovas, MD, Centre Hospitalier Universitaire, Dijon, France; Jason R. Westin, MD, The University of Texas MD Anderson Cancer Center, Houston, TX; Mark Roschewski, MD; and Wyndham H. Wilson, MD, PhD, National Institutes of Health, Bethesda, MD; Gianluca Gaidano, MD, PhD; and Davide Rossi, MD, PhD, University of Eastern Piedmont, Novara, Italy, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland; and Maximilian Diehn, MD, PhD; and Ash A. Alizadeh, MD, PhD, Stanford University, Stanford, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.01907
Publisher Site
http://dx.doi.org/10.1200/JCO.18.01907DOI Listing
March 2019

Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA.

Best Pract Res Clin Haematol 2018 09 3;31(3):285-292. Epub 2018 Jul 3.

Lymphoid Malignancies Branch, CCR, NCI, Building 10, Room 4N115, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.07.004DOI Listing
September 2018

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2018 10 20;36(28):2845-2853. Epub 2018 Aug 20.

David M. Kurtz, Florian Scherer, Michael C. Jin, Joanne Soo, Alexander F.M. Craig, Mohammad Shahrokh Esfahani, Jacob J. Chabon, Henning Stehr, Chih Long Liu, Robert Tibshirani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, Ranjana H. Advani, Ronald Levy, Aaron M. Newman, Maximilian Diehn, and Ash A. Alizadeh, Stanford University, Stanford, CA; Florian Scherer, University Medical Center Freiburg, Freiburg; Ulrich Dührsen and Andreas Hüttmann, University Hospital Essen, Essen, Germany; Michel Meignan, Hôpitaux Universitaires Henri Mondor, Creteil; René-Olivier Casasnovas, Hôpital Le Bocage, Centre Hospitalier Universitaire, Dijon, France; Jason R. Westin, University of Texas MD Anderson Cancer Center, Houston, TX; Mark Roschewski and Wyndham H. Wilson, National Cancer Institute, National Institutes of Health, Bethesda, MD; Gianluca Gaidano and Davide Rossi, University of Eastern Piedmont, Novara, Italy; and Davide Rossi, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.5246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161832PMC
October 2018

Genetics of Diffuse Large B-Cell Lymphoma.

N Engl J Med 2018 08;379(5):493-494

National Cancer Institute, Bethesda, MD

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1806191DOI Listing
August 2018

End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams

Haematologica 2018 08;103(8):e382

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.199547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068019PMC
August 2018

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

N Engl J Med 2018 04;378(15):1396-1407

From the Lymphoid Malignancies Branch (R.S., D.W.H., J.D.P., J.Q.W., S.R., M.K., R.M.Y., A.L.S., D.J.H., W. Xiao, X.Y., Y.Y., H.Z., W. Xu, W.H.W., L.M.S.), the Biometric Research Program, Division of Cancer Diagnosis and Treatment (G.W.W.), and the Laboratory of Pathology, Center for Cancer Research (E.S.J., S.P.), National Cancer Institute, and the Office of Intramural Research, Center for Information Technology (C.A.J., X.L., B.Z., W.D.), National Institutes of Health, Bethesda, and the Cancer Research Technology Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick (B.T., J.S., Y.Z., D.R.S.) - all in Maryland; the Department of Pathology, City of Hope National Medical Center, Duarte, CA (W.C.C.); the BC Cancer Agency, Vancouver, BC (R.D.G., J.M.C.), and the University Health Network, Laboratory Medicine Program, Toronto General Hospital and University of Toronto, Toronto (J.D.) - both in Canada; the Hospital Clinic of Barcelona, University of Barcelona, Institute for Biomedical Research August Pi I Sunyer, Barcelona (E.C., A.L.-G.); the Institute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken, Würzburg (A.R.), and the Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart (G.O.) - all in Germany; the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ (L.M.R.); the National Cancer Centre of Singapore, Singapore (K.T.K.W.); Memorial Sloan Kettering Cancer Center (A.D.Z.) and Weill Cornell Medicine (J.P.L.) - both in New York; the Department of Medicine, Washington University School of Medicine, St. Louis (N.L.B.); and the Alliance for Clinical Trials in Oncology, Chicago (A.D.Z., J.P.L., N.L.B.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1801445
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1801445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010183PMC
April 2018

What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R?

Br J Haematol 2019 03 13;184(5):836-838. Epub 2018 Mar 13.

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15185DOI Listing
March 2019

The landscape of new drugs in lymphoma.

Nat Rev Clin Oncol 2017 Jun 29;14(6):335-346. Epub 2016 Dec 29.

UNMC Oncology/Haematology Division, 987680 Nebraska Medical Center, Omaha, Nebraska 681980-7680, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611863PMC
June 2017

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.

J Natl Cancer Inst 2016 12 16;108(12). Epub 2016 Dec 16.

Department of Medicine, Mayo Clinic, Rochester, MN (GSN); Department of Internal Medicine, Ohio State University, Columbus, OH (KAB); Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF); Coordinating Center for Clinical Trials (LB), Division of Cancer Treatment and Diagnosis (RFL), and Center for Cancer Research (WHW), National Cancer Institute, National Institute of Health, Bethesda, MD; Division of Oncology, University of Washington, Seattle WA (DGM); British Colombia Cancer Agency, Vancouver, BC (LHS); Department of Medicine, University of Virginia, Charlottesville, VA (MEW); Department of Medicine, Weil Cornell University, New York, NY (JPL); Department of Medicine, University of Chicago, Chicago, IL (SMS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080361PMC
December 2016

Update on Burkitt Lymphoma.

Hematol Oncol Clin North Am 2016 Dec;30(6):1333-1343

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2016.07.009DOI Listing
December 2016

Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas.

Leuk Lymphoma 2016 07 17;57(7):1616-24. Epub 2016 May 17.

a Lymphoid Malignancy Branch, Center for Cancer Research , National Cancer Institute , Bethesda , MD , USA ;

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2015.11
Publisher Site
http://dx.doi.org/10.3109/10428194.2015.1118476DOI Listing
July 2016

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

Blood 2016 06 14;127(25):3127-32. Epub 2016 Apr 14.

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-03-635219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920019PMC
June 2016

Progress in Chronic Lymphocytic Leukemia with Targeted Therapy.

Authors:
Wyndham H Wilson

N Engl J Med 2016 Jan;374(4):386-8

From the Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1515235DOI Listing
January 2016

Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma.

Haematologica 2016 Jan 30;101(1):e27-9. Epub 2015 Oct 30.

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.131151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697904PMC
January 2016

Cracking the diverse biologic code of diffuse large B-cell lymphoma.

Semin Hematol 2015 Apr 21;52(2):55-6. Epub 2015 Jan 21.

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2015.01.010DOI Listing
April 2015

Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma.

Oncotarget 2015 Sep;6(29):27332-42

Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.2903DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694993PMC
September 2015

Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency.

J Clin Lipidol 2015 Jan-Feb;9(1):81-90. Epub 2014 Oct 5.

Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA; Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2014.09.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513489PMC
October 2015

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

Blood 2015 Jan 11;125(1):33-9. Epub 2014 Dec 11.

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2014-05
Publisher Site
http://dx.doi.org/10.1182/blood-2014-05-575092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281829PMC
January 2015

Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations.

Am J Surg Pathol 2015 Feb;39(2):141-56

*Laboratory of Pathology ‡Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD †Department of Pathology and Laboratory Medicine, City of Hope Medical Center, Duarte, CA §Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293220PMC
http://dx.doi.org/10.1097/PAS.0000000000000328DOI Listing
February 2015

A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.

Clin Nucl Med 2014 Oct;39(10):874-81

From the *Molecular Imaging Program, and †Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD; ‡Brookhaven National Laboratories, Upton, NY; and §SAIC Contractor to NCI, Fort Detrick Frederick, MD; and ¶Lymphoma Therapeutics Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838032PMC
October 2014

The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphoma.

Leuk Lymphoma 2015 Mar 15;56(3):682-7. Epub 2014 Jul 15.

Biostatistics Branch, Division of Cancer Epidemiology and Genetics.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2014.92
Publisher Site
http://dx.doi.org/10.3109/10428194.2014.921914DOI Listing
March 2015

Appropriate management of molecular subtypes of diffuse large B-cell lymphoma.

Oncology (Williston Park) 2014 Apr;28(4):326-34

View Article

Download full-text PDF

Source
April 2014

Management of heavy chain diseases: the challenges of biologic heterogeneity.

Oncology (Williston Park) 2014 Jan;28(1):63-5

View Article

Download full-text PDF

Source
January 2014

Moving beyond rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for diffuse large B-cell lymphoma.

Leuk Lymphoma 2014 Nov 7;55(11):2428-37. Epub 2014 Mar 7.

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.883075DOI Listing
November 2014

Treatment strategies for aggressive lymphomas: what works?

Authors:
Wyndham H Wilson

Hematology Am Soc Hematol Educ Program 2013 ;2013:584-90

1Lymphoid Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2013.1.584DOI Listing
July 2014

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia.

Clin Cancer Res 2013 Dec 25;19(24):6873-81. Epub 2013 Nov 25.

Authors' Affiliations: Laboratories of Molecular Biology, Pathology, and Metabolism Branch, National Cancer Institute; and Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867590PMC
December 2013

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

Nat Rev Clin Oncol 2014 Jan 12;11(1):12-23. Epub 2013 Nov 12.

Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10 Room 4N115, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2013.197
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2013.197DOI Listing
January 2014

Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.

Clin Cancer Res 2013 Nov 4;19(22):6313-21. Epub 2013 Oct 4.

Authors' Affiliations: Laboratories of Molecular Biology and Pathology, and Metabolism Branch, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861900PMC
November 2013

Implications of the shifting pathobiology of AIDS-related lymphoma.

J Natl Cancer Inst 2013 Aug 26;105(16):1170-1. Epub 2013 Jul 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt192DOI Listing
August 2013

B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency.

J Clin Immunol 2013 Aug 26;33(6):1062-6. Epub 2013 Jun 26.

Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10875-013-9907-0
Publisher Site
http://dx.doi.org/10.1007/s10875-013-9907-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729015PMC
August 2013

T-cell lymphoma.

Best Pract Res Clin Haematol 2013 Mar 23;26(1). Epub 2013 May 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2013.05.001DOI Listing
March 2013

Bcl-2 level as a biomarker for 13q14 deletion in CLL.

Cytometry B Clin Cytom 2013 Jul-Aug;84(4):237-47. Epub 2013 May 14.

Center for Biologics Evaluation and Research, FDA, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963274PMC
February 2014

Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.

Ther Adv Hematol 2013 Feb;4(1):43-57

Metabolism Branch, National Cancer Institute, Building 10, Room 4N-115, 9000 Rockville Pike, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620712464508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629761PMC
February 2013

Diffuse large B cell lymphoma: molecular targeted therapy.

Int J Hematol 2012 Nov 20;96(5):552-61. Epub 2012 Oct 20.

Lymphoma Therapeutics Section, Metabolism Branch, National Cancer Institute, NIH, 9000 Rockville Pike, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12185-012-1198-3
Publisher Site
http://dx.doi.org/10.1007/s12185-012-1198-3DOI Listing
November 2012

Lymphomatoid granulomatosis.

Cancer J 2012 Sep-Oct;18(5):469-74

Hematologic Malignancy Section, Walter Reed National Military Medical Center, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e31826c5e19DOI Listing
April 2013

Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?

Curr Hematol Malig Rep 2012 Sep;7(3):241-7

Metabolism Branch, Center for Cancer Research, National Cancer Institute, Rockville Pk, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-012-0130-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329459PMC
September 2012